Related Experiment Video
Updated: Mar 21, 2026

Implantation of Left Ventricular Assist Device (LVAD) in Juvenile Landrace Swine: A LVAD Implantation Model of Pediatric Heart Failure
Published on: January 16, 2026
Compassionate deactivation of ventricular assist devices in pediatric patients
Seth A Hollander1, David M Axelrod1, Daniel Bernstein1
1Department of Pediatrics (Cardiology), Stanford University Medical Center, Palo Alto, California, USA.
Insights
Compassionate deactivation of ventricular assist devices (VADs) in children with heart failure lacks guidelines. Establishing ethical protocols is crucial as more children die on mechanical support.
Area of Science:
- Pediatric Cardiology
- Palliative Care
- Bioethics
Background:
- Ventricular assist devices (VADs) improve survival in pediatric end-stage heart failure but do not eliminate mortality.
- Increasing complexity of cases and destination therapy means more children may die while on mechanical support.
- Current guidelines for compassionate VAD deactivation in children are absent.
Discussion:
- The increasing frequency of VAD use in children necessitates urgent development of ethical and pragmatic guidelines for compassionate deactivation.
- Addressing patient, family, and clinician attitudes towards deactivation is essential.
- Education on psychological, legal, and ethical aspects of deactivation is needed.
Key Insights:
- Lack of established guidelines for compassionate VAD deactivation in pediatric end-stage heart failure.
- Anticipated increase in pediatric deaths on mechanical support highlights the need for clear protocols.
- Multidisciplinary collaboration between pediatric heart failure and palliative care teams is vital.
Outlook:
- Development of pediatric-specific advance care planning documents for VAD implantation.
- Creation of deactivation checklists to aid decision-making during critical illness points.
- Future research should focus on patient/family preferences and ethical frameworks for VAD deactivation in children.
Abstract:
Despite greatly improved survival in pediatric patients with end-stage heart failure through the use of ventricular assist devices (VADs), heart failure ultimately remains a life-threatening disease with a significant symptom burden. With increased demand for donor organs, liberalizing the boundaries of case complexity, and the introduction of destination therapy in children, more children can be expected to die while on mechanical support. Despite this trend, guidelines on the ethical and pragmatic issues of compassionate deactivation of VAD support in children are strikingly absent. As VAD support for pediatric patients increases in frequency, the pediatric heart failure and palliative care communities must work toward establishing guidelines to clarify the complex issues surrounding compassionate deactivation. Patient, family and clinician attitudes must be ascertained and education regarding the psychological, legal and ethical issues should be provided. Furthermore, pediatric-specific planning documents for use before VAD implantation as well as deactivation checklists should be developed to assist with decision-making at critical points during the illness trajectory. Herein we review the relevant literature regarding compassionate deactivation with a specific focus on issues related to children.
More Related Videos
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Cardiopulmonary Resuscitation III: AED Use
Mechanical Ventilation II: Invasive Ventilation
Negative-Pressure Ventilators
Negative-pressure ventilators create a vacuum around the chest or body to draw air into the lungs, simulating breathing. This method does not require an...
Mechanical Ventilation III: Noninvasive Ventilation
Noninvasive Positive-Pressure Ventilation...
Cardiopulmonary Resuscitation I: Adult
Cardiomyopathy II: Dilated Cardiomyopathy

